 islet amyloid polypeptide significant factor pathogenesis pathophysiology diabetes Islet amyloid polypeptide IAPP amylin minor secretory peptide beta-cell gene-related peptide CGRP constituent amyloid deposits islets many non-insulin-dependent type II diabetic individuals elderly nondiabetic subjects IAPP small precursor level insulin beta-granules insulin C-peptide Analysis gene chromosome evolutionary relationship CGRP peptides shares biological actions CGRP IAPP action insulin level muscle glycogen synthesis levels effect circulating levels evidence overproduction IAPP diabetic subjects work necessary normal secretory rates clearance Other proposed actions IAPP serum calcium-lowering effects smooth muscle relaxation latter effect uptake insulin circulation islets Deposition amyloid species selective due structural differences central part molecule type II several mechanisms differences structure IAPP precursor individuals maturity-onset diabetes young type II diabetes